logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Sunday, June 29, 2025 · 826,750,332 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Pharmaceutical Industry First Quarter Profit News Monitoring

  • Published on Jun 24, 2025

    Ozon Pharmaceuticals will pay dividends for the first quarter of 307.6 million rubles

    AK&M 24 June 2025 18:22 PJSC Ozon Pharmaceuticals will pay dividends for the first quarter of 2025 in the amount of 307.6 million rubles. 0.28 rubles were accrued per share. This is stated in the company's message. Recall that in 2024 it was …

    Source: AK&M - Pending
  • Published on 00:13 GMT

    Vietnamese Shoppers Tackle the Challenge of Identifying Fake Products in a Complex Retail Landscape

    In early April, a 60-year-old woman in Hanoi visited the doctor, troubled by persistent joint pain that refused to ebb even under a regimen of various supplements. The diagnosis was disheartening: joint degeneration, osteoporosis, and herniated discs. Even …

    Source: Retail News Asia - Pending
  • Published on Jun 26, 2025

    Steve Cohen's Point72 Goes Heavy on Tech and Pharma Stocks, Investing Over $330M in Two Trades

    Billionaire investor and hedge fund manager Steven A. Cohen moves with speed and agility when it comes to investing. The New York Mets owner recently bet over £240.72 million ($330 million) across two stock trades, according to the latest regulatory …

    Source: International Business Times - United Kingdom - Neutral
  • Published on Jun 25, 2025

    Budapest Stock Exchange: Q1 Profit Over HUF 1.3 Bn

    The net profit of the Budapest Stock Exchange (BSE) for the first quarter of 2025, which includes the BSE's share of the KELER Group's results, is HUF 1,31 billion, BSE announced on its website this Tuesday. The EBITDA value in the first quarter of …

    Source: Diplomacy & Trade - Pending
  • Published on Jun 28, 2025

    Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future

    Hims & Hers, the high-flying telehealth company that rapidly ascended from a buzzy startup selling Viagra to a multibillion-dollar business with a Super Bowl ad, had a hard week. The San Francisco company’s shares took a dive Monday after its …

    Source: Los Angeles Times - Center-left
  • Published on Jun 26, 2025

    Creo Medical updates investors on growth strategy and US opportunity

    Creo Medical Group PLC (AIM:CREO) said it was confident of delivering another year of growth as it prepared to host its annual meeting in Bristol on Thursday. The company, which specialises in surgical endoscopy devices used to treat early-stage cancers, …

    Source: Proactive UK - Neutral
  • Published on Jun 28, 2025

    Checking In on the Economy and Some Stocks Worth Watching

    Ricky Mulvey: The thing that doesn't make sense to me, David, is you heard Powell talking about how a lot of companies were pulling things forward to get ahead of tariffs. Liberation Day was April. We still have April and May in Quarter 2, and they…

    Source: Yahoo Finance - Center-left
  • Published on Jun 28, 2025

    How to Invest $21,000 Across Three Years of TFSA Contributions

    When you’ve got $21,000 to invest in your Tax-Free Savings Account (TFSA) across three years, it’s tempting to rush and pick the hottest stock on the market. But the smarter move is to choose a balanced trio that offers growth, income, and resilience. With …

    Source: The Motley Fool Canada - Neutral
  • Published on Jun 27, 2025

    Should You Hold ICON PLC (ICLR)?

    Wasatch Global Investors, an asset management company, released its “Wasatch U.S. Select Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities declined in the first quarter due to potential tariffs and …

    Source: Yahoo Finance - Center-left
  • Published on Jun 27, 2025

    BioCryst To Sell European Business Of Its Hereditary Angioedema Drug To Pay Off Debt: Stock Rises While Retail Stays ...

    BioCryst Pharmaceuticals, Inc. (BCRX) on Friday said that it has entered into a definitive agreement to sell its European Orladeyo business to Italian pharmaceutical company Neopharmed Gentili for up to $264 million. BCRX shares were up by over 4% in the …

    Source: Asianet Newsable - Center-right
  • Published on Jun 27, 2025

    THE FRIDAY 5: C&S Acquiring SpartanNash; Kroger Plans for Store Closures

    While Kroger posted solid Q1 financial results, the grocer also announced plans to close more than 60 of its stores over the next 18 months. 3. Kroger Plans Store Closures Amid Q1 Sales Uptick In the midst of reporting its financial performance for Q1 late …

    Source: Progressive Grocer - Center-left
  • Published on Jun 27, 2025

    Got $500? 1 Real Estate Stock to Buy and Hold Forever

    When you’re starting small, you want to make sure every dollar counts. A $500 investment won’t make you rich overnight, but it can start something powerful, especially if you choose the right stock and hold it long term. One Canadian real estate investment …

    Source: The Motley Fool Canada - Neutral
  • Published on Jun 26, 2025

    Bavarian Nordic begins mpox vaccine trial in pregnant women and infants

    Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women, as well as infants aged under two years. The first infants have been dosed in one Phase III study (NCT06844487), which aims to …

    Source: Clinical Trials Arena - Pending
  • Published on Jun 27, 2025

    Opinion: Can Telangana become USD 1 trillion economy?

    With a decade of groundwork, the runway is ready — now it’s time to chart the right policies for takeoff and activate growth engines By Prof Prabhakar Reddy Tada Telangana is one of the fastest-growing economies in the country, with an average annual …

    Source: Telengana Today - Indeterminate
  • Published on Jun 25, 2025

    Germany will be first launch for PTC's phenylketonuria drug

    The European Commission has approved PTC Therapeutics' treatment for the rare disease phenylketonuria (PKU), Sephience, setting up a market debut in Germany next month. Sephience (sepiapterin) has been given a broad label for the treatment of children …

    Source: pharmaphorum - Neutral
  • Published on Jun 27, 2025

    Records: Potential partners are 10

    PORT ANGELES — If the Olympic Medical Center board of commissioners approves a letter of intent with a health care system to establish the framework for a partnership, it will be with one of 10 organizations that signed mutual confidentiality and non- …

    Source: Peninsula Daily News - Washington State - Neutral
  • Published on Jun 27, 2025

    Merchandise-trade deficit widens

    The U.S. merchandise-trade deficit unexpectedly widened in May on the biggest drop in exports since the onset of the pandemic, while imports were little changed. The shortfall in goods trade grew 11.1% to $96.6 billion, Commerce Department data showed …

    Source: Northwest Arkansas Democrat Gazette - Pending
  • Published on Jun 27, 2025

    Prime Therapeutics' leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

    Findings also show improved persistence with high-potency, obesity-approved GLP-1 products EAGAN, Minn., June 25, 2025 /PRNewswire/ -- Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without …

    Source: The Bulletin - Kansas - Neutral
  • Published on Jun 27, 2025

    US close: Tech stocks lift markets as S&P 500, Nasdaq near record highs

    The Dow gained 0.94% to 43,386.84, its highest since 28 February. The S&P 500 rose 0.80% to 6,141.02, its highest since 19 February when it settled at a record-high close of 6,144.15. Meanwhile, the Nasdaq jumped 0.97% to 20,167.91, not far off its all …

    Source: ShareCast - Neutral

02 days 18:20:58

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 826,750,332 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 06/17/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement